🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the efficacy and safety of CD22/C...
Status
Recruiting
Location
Chinese PLA General Hospital, Beijing, Beijing 100853
Start Date
2026-04-01
Trial ID
NCT07779018
Treatments Being Tested
For patients with recurrent liver cancer after liver transplantation, the m...
Status
Unknown
Location
Department of Liver Transplantation, the Third Affiliated Hospital of Sun Yat-sen University
Start Date
2023-12-03
Trial ID
NCT05833126
Treatments Being Tested
To meet the needs of newborns in neonatal intensive care and ensure long-te...
Status
Not Yet Recruiting
Location
CHU Clermont-Ferrand
Start Date
2025-07-01
Trial ID
NCT06813326
Treatments Being Tested
There is currently no standardized treatment for patients who have undergon...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-08-16
Trial ID
NCT06063018
Treatments Being Tested
BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common chronic ...
Status
Unknown
Location
IRCCS G. Gaslini
Start Date
2011-12
Trial ID
NCT01399281
This is an open-label, multicenter, randomized, Phase 3 study in patients w...
Status
Completed
Location
Arizona Cancer Center
Start Date
2018-09-15
Trial ID
NCT03665441
Treatments Being Tested
Anlotinib is a multi-target receptor tyrosine kinase inhibitor in domestic ...
Status
Completed
Location
Nong Yang
Start Date
2021-01-30
Trial ID
NCT05001971
Treatments Being Tested
Approximately 20-50% of patients with colorectal cancer (CRC) develop dista...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-05-10
Trial ID
NCT07604909
Treatments Being Tested
This study compares the efficacy and safety of sulodexide (Vessel) to place...
Status
Unknown
Location
CardioVasc s.r.o.
Start Date
2021-11-25
Trial ID
NCT05005052
This is an open label phase 2 study using metronomic doses of trabectedin, ...
Status
Recruiting
Location
Sant P Chawla
Start Date
2021-09-09
Trial ID
NCT04535271
Treatments Being Tested